Iterum Therapeutics ITRM

$ 1.77 8.59%

Quarterly report 2024-Q3
added 11-14-2024

Iterum Therapeutics Balance Sheet 2011-2024 | ITRM

Annual Balance Sheet Iterum Therapeutics

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	5.75 M	-10.7 M	-20.1 M	21.9 M	8.62 M	-30.5 M	-8.48 M	-24.8 M	-	-	-	-	-
Long Term Debt	11.5 M	10.1 M	6.93 M	35.9 M	7.62 M	13.1 M	-	-	-	-	-	-	-
Long Term Debt Current	365 K	332 K	464 K	573 K	580 K	1.02 M	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	15 M	14 M	137 K	30 K	-	-	-	-	-
Total Current Liabilities	13.5 M	9.06 M	12.9 M	41.7 M	37 M	12.2 M	-	-	-	-	-	-	-
Total Liabilities	32.7 M	38.8 M	41.3 M	83.4 M	52 M	26.2 M	7.26 M	4.25 M	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-461 M	-423 M	-378 M	-287 M	-235 M	-132 M	-54.7 M	-25.3 M	-	-	-	-	-
Total Assets	26.3 M	66.8 M	91.5 M	32.8 M	25.8 M	97.9 M	46.8 M	26.9 M	-	-	-	-	-
Cash and Cash Equivalents	6.07 M	21.1 M	27.4 M	14.5 M	4.8 M	44.6 M	-	-	-	-	-	-	-
Book Value	-6.4 M	28 M	50.2 M	-50.6 M	-26.2 M	71.6 M	39.5 M	22.7 M	-	-	-	-	-
Total Shareholders Equity	-6.4 M	28 M	50.2 M	-50.6 M	-26.2 M	71.6 M	39.5 M	22.7 M	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Iterum Therapeutics

	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	11.2 M	11.2 M	11.2 M	12.5 M	11.7 M	10.9 M	10.1 M	9.3 M	8.5 M	7.71 M	6.93 M	6.13 M	5.34 M	6.09 M	22.5 M	22.5 M	22.5 M	22.5 M	7.62 M	7.62 M	7.62 M	7.62 M	13.1 M	13.1 M	13.1 M	13.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	27.4 M	25.1 M	25.8 M	36.3 M	43.9 M	39.2 M	38.8 M	39 M	32.8 M	35.4 M	41.3 M	46 M	58.8 M	83.6 M	83.4 M	83.4 M	83.4 M	83.4 M	52 M	52 M	52 M	52 M	26.2 M	26.2 M	26.2 M	26.2 M	7.21 M	7.21 M	7.21 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-479 M	-473 M	-468 M	-449 M	-445 M	-433 M	-423 M	-418 M	-389 M	-382 M	-378 M	-374 M	-378 M	-386 M	-287 M	-287 M	-287 M	-287 M	-235 M	-235 M	-235 M	-235 M	-132 M	-132 M	-132 M	-132 M	-54.7 M	-54.7 M	-54.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	15.9 M	14.2 M	19.6 M	39.7 M	51 M	58.1 M	66.8 M	71.6 M	76.7 M	84.1 M	91.5 M	98.4 M	106 M	115 M	32.8 M	32.8 M	32.8 M	32.8 M	25.8 M	25.8 M	25.8 M	25.8 M	97.9 M	97.9 M	97.9 M	97.9 M	46.8 M	46.8 M	46.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	13.4 M	4.98 M	7.39 M	4.82 M	13.7 M	16.8 M	21.1 M	20.5 M	9.21 M	31.4 M	27.4 M	36 M	36.6 M	66.6 M	14.5 M	14.5 M	14.5 M	14.5 M	4.8 M	4.8 M	4.8 M	4.8 M	44.6 M	44.6 M	44.6 M	44.6 M	8.48 M	8.48 M	8.48 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-11.5 M	-10.9 M	-6.15 M	3.43 M	7.13 M	19 M	28 M	32.5 M	43.9 M	48.6 M	50.2 M	52.4 M	47.2 M	31.5 M	-50.6 M	-50.6 M	-50.6 M	-50.6 M	-26.2 M	-26.2 M	-26.2 M	-26.2 M	71.6 M	71.6 M	71.6 M	71.6 M	39.6 M	39.6 M	39.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-11.5 M	-10.9 M	-6.15 M	3.43 M	7.13 M	19 M	28 M	32.5 M	43.9 M	48.6 M	50.2 M	52.4 M	47.2 M	31.5 M	50.6 M	-50.6 M	-50.6 M	-50.6 M	-26.2 M	-26.2 M	-26.2 M	-26.2 M	71.6 M	71.6 M	71.6 M	71.6 M	39.5 M	39.5 M	39.5 M	-	22.7 M	-	-	-	15 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency